Astrazeneca Share News (AZN)

Astrazeneca Information

Buy AZN Shares
Add AZN to Watchlist
Add AZN to Alert

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 12,050.00

Bid: 12,038.00

Ask: 12,040.00

Change: -106.00 (-0.87%)

Spread: 2.00 (0.017%)

Open: 12,092.00

High: 12,178.00

Low: 12,010.00

Prev. Close: 12,156.00

Last checked at -

London pre-open: Chinese PMI data to drag FTSE lower early on

Sun, 02nd Nov 2014 17:33

Tracking a weaker session in Asia overnight, UK stocks are expected to begin a macro-focused week with small gains.City sources predict the FTSE 100 will open around nine points lower than Friday's close of 6,546.47."As we approach a major week in the markets in terms of economic events, we are likely to see more caution creep in as traders seek to gain their sentiment through the various releases throughout the week," said Alpari market analyst Joshue Mahony.The weakness is largely due to the slowdown seen in Chinese manufacturing growth in October that was announced on Saturday.According the National Bureau of Statistics, the country's official purchasing managers index (PMI) dropped to 50.8 from 51.1 in September, although this was marginally higher than the figure of 50.4 that was given by HSBC on Monday morning."The fact of the matter is that the one sector that matters is manufacturing, yet for two and a half years, the sector has failed to gain any sort of meaningful traction, with a peak of 51.7 compared to a reading of 59.2 recorded in mid-2008," Mahony said.The news reversed gains seen on Friday, which came after Japan announced it will put half of its holdings in local and foreign stocks, doubling previous levels, and invest in alternative assets.The Bank of Japan last week raised its annual target for monetary expansion to 80trn yen ($724bn) from 70trn yen.Closer to home, both the US and Europe will both also see the release of manufacturing PMI data in Monday's session, with readings from the latter expected to be mixed.In company news, Diageo has agreed on an asset-swap deal with Casa Cuervo which will see the UK spirits group take full control of tequila label Don Julio in exchange for selling its Bushmills whisky brand. The deal, which also involves the early termination of Case Cuervo's production and distribution agreement for Smirnoff in Mexico, will result in a net payment of $408m to Diageo on completion.Drugs maker Astrazeneca has completed the transfer of the development and commercialisation rights to Almirall's respiratory franchise, paying an initial $875m, plus up to a further $1.22bn in development, launch and sales-related milestones. The deal is expected to be neutral to core earnings per share in 2015 and accretive from 2016.Ryanair's first half profits flew 32% higher to €795m on Monday thanks to a strong summer and the budget airline's customer charm offensive, involving the introduction of allocated seating, extra free hand baggage and new initiatives to lure business travellers.

More News

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

Latest Share Chat

Astrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: Chinese PMI data to drag FTSE lower early on

Login to your account

Quickpicks are a member only feature

Login to your account